| 1 |
2012-02-22 |
11309 |
Ascomycin
|
| 5 mg | $39.00 |
| 10 mg | $74.00 |
| 25 mg | $120.00 |
|
11011-38-4 |
≥98%
|
 |
|
17.138332071949
|
ascomycin
|
L 683590; FR 900520; FK 520; Changchuanmycin; FR 520; Immunomycin
|
11011-38-4 126340-36-1 133876-12-7 136457-58-4 137767-75-0 148400-02-6 159430-76-9 FK-520 FR-520 FR-900520 L-683590 |
| 2 |
2012-02-22 |
11426 |
Beauvericin
A mycotoxin which induces apoptosis
Beauvericin is a mycotoxin originally derived from Beauveria bassiana, a common fungal parasite of arthropods. It is also produced by the fungus Fusarium, a pathogen of insects and plants. Beauvericin is cytotoxic against insect cells, killing the insect cell line SF-9 with a 50% cytotoxic concentration of 2.5 μM. In mammalian cells, beauvericin induces apoptosis with an IC50 of 4.5 μM. |
| 1 mg | $24.00 |
| 5 mg | $108.00 |
| 10 mg | $192.00 |
|
26048-05-5 |
≥98%
|
 |
|
0E-12
|
beauvericin
|
|
toxins mycotoxins fungus insects apoptosis Beauveria bassiana B. bassiana fungal parasites arthropods fusarium pathogens cells SF-9 |
| 3 |
2012-02-22 |
11304 |
BSI-201
|
| 50 mg | $39.00 |
| 100 mg | $74.00 |
| 250 mg | $176.00 |
|
160003-66-7 |
≥98%
|
 |
|
0E-12
|
bsi-201
|
NSC 746045; Iniparib; IND 71677
|
937799-96-7 |
| 4 |
2012-02-22 |
11328 |
Cytochalasin B
|
| 1 mg | $20.00 |
| 5 mg | $90.00 |
| 10 mg | $160.00 |
|
14390-96-2 |
≥98%
|
 |
|
0E-12
|
cytochalasin-b
|
Phomin; NSC 107658
|
11032-95-4 11042-65-2 16006-03-4 21476-12-0 |
| 5 |
2012-02-22 |
11427 |
Diacetoxyscirpenol
|
| 1 mg | $27.00 |
| 5 mg | $122.00 |
| 10 mg | $216.00 |
|
2270-40-8 |
≥98%
|
 |
|
0E-12
|
diacetoxyscirpenol
|
NSC 141537; Anguidine; NSC 177378; DAS
|
11011-10-2 22135-66-6 25662-95-7 28776-47-8 109547-11-7 145427-91-4 852223-87-1 scirpenetriol |
| 6 |
2012-02-22 |
11332 |
Fumagillin
|
| 1 mg | $16.00 |
| 5 mg | $72.00 |
| 10 mg | $128.00 |
|
23110-15-8 |
≥95%
|
 |
|
0E-12
|
fumagillin
|
NSC; Amebacilin
|
297-95-0, 47721-00-6 47721-01-7 106215-84-3 746540-00-1 fugillin fumadil B fumagillin fumagillin DCH fumidil |
| 7 |
2012-02-22 |
11203 |
Phenylpiperazine (hydrochloride)
A designer drug
Phenylpiperazine is the base compound from which a broad series of bioactive products are derived. Many are entactogenic drugs which induce central serotonin release. Substituted phenylpiperazines, such as 1-(3-chlorophenyl)piperazine, have been identified as designer drugs or drugs of abuse. This product is intended for forensic applications. |
| 10 mg | $18.00 |
| 50 mg | $81.00 |
| 100 mg | $144.00 |
|
4004-95-9 |
≥98%
|
 |
|
98.148148148148
|
phenylpiperazine-hydrochloride
|
NSC 38914; NSC 150847
|
EINECS 218-646-9 NSC38914 NSC-38914 ST088126 92-54-6 chloride AC1L2O6F AC1Q38T6 AR-1C5346 AR1C5346 NSC15084 NSC-150847 101-3441 forensics designer drugs 5-HT serotonin piperazines |
| 8 |
2012-02-22 |
11350 |
Thiolutin
|
| 1 mg | $38.00 |
| 5 mg | $171.00 |
| 10 mg | $304.00 |
|
87-11-6 |
≥97%
|
 |
|
0E-12
|
thiolutin
|
Acetopyrrothin; NSC 3927
|
|
| 9 |
2012-02-22 |
11353 |
Zearalenone
|
| 5 mg | $31.00 |
| 10 mg | $59.00 |
| 25 mg | $140.00 |
|
17924-92-4 |
≥98%
|
 |
|
0E-12
|
zearalenone
|
Zenone; Toxin F2; FES; Mycotoxin F2
|
18695-28-8 |
| 10 |
2012-02-21 |
11205 |
1-(m-Trifluoromethylphenyl) piperazine (hydrochloride)
A designer drug
1-(m-Trifluoromethylphenyl) piperazine (TFMPP) is an entactogenic drug which selectively promotes the release of serotonin. When used in combination with 1-benzylpiperazine, TFMPP increases both serotonin and dopamine, mirroring the effects of 3,4-methylenedioxymethamphetamine. Drug-drug synergism may induce seizures. TFMPP has been identified in party pills and powders. Its metabolism in rats has been described. This product is intended for forensic applications. |
| 10 mg | $18.00 |
| 50 mg | $81.00 |
| 100 mg | $144.00 |
|
76835-14-8 |
≥98%
|
 |
|
138.000000000000
|
1-m-trifluoromethylphenyl-piperazine-hydrochloride
|
TFMPP
|
EINECS 239-574-4 NSC128882 NSC-12882 STK397247 AG-E-03624 T-6427 LS-184023 15532-75-9 forensics piperazine phenylpiperazine designer drugs 5-HT serotonin dopamine MDMA BZP party pills powders seizures metabolism rats |
| 11 |
2012-02-21 |
11320 |
Citrinin
A mycotoxin that disrupts microtubule organization
Citrinin is a mycotoxin originally isolated from Penicillium citrinum that is also produced by a variety of other fungi that are found as contaminants in human foodstuffs and animal feeds. Citrinin exerts cytotoxic and genotoxic effects in various mammalian cells, causing mycotoxic nephropathy in livestock and Balkan nephropathy and yellow rice fever in humans. Because citrinin induces apoptosis and blocks tubulin polymerization as well as mitotic spindle assembly, it is useful as a biological research reagent. |
| 1 mg | $15.00 |
| 5 mg | $68.00 |
| 10 mg | $120.00 |
|
518-75-2 |
≥98%
|
 |
|
98.888888888889
|
citrinin
|
NSC 186
|
11003-17-1 16051-41-5 mycotoxin food contaminants cytotoxin mycotoxic Balkan nephropathy yellow rice fever apoptosis tubulin polymerization microtubule organization Penicillium citrinum P. citrinum |
| 12 |
2012-02-21 |
9001108 |
Docosahexaenoyl Ethanolamide-d4
An internal standard for the quantification of docosahexaenoyl ethanolamide
Docosahexaenoyl ethanolamide-d4 contains four deuterium atoms at the 1, 1', 2, and 2' positions. It is intended for use as an internal standard for the quantification of docosahexaenoyl ethanolamide by GC- or LC-mass spectrometry (MS). |
| 500 µg | $49.00 |
| 1 mg | $93.00 |
| 5 mg | $392.00 |
| 10 mg | $686.00 |
|
946524-43-2 |
≥99% deuterated forms (d1-d4)
|
 |
✓ |
223.174174340086
|
docosahexaenoyl-ethanolamide-d4
|
DHEA-d4; DEA-d4
|
neurochemistry neuroscience endocannabinoids brain retina docosahexaenoic acids DHA fatty w-3 .omega.-3 neural tissues ethanolamines ethanolamides arachidonoyl AEA lipids extracts piglets diets rats CB1 receptors shaker-related voltage-gated potassium channels cannabinoids cbs synthetic DEA deuterateds deuteriums LC-MS GC/MS GC-MS mass spectrometry LC/MS MS |
| 13 |
2012-02-21 |
11174 |
Ercalcitriol
A dihydroxy- derivative of vitamin D2
Ercalcitriol is the active circulating metabolite of vitamin D2 formed by 25-hydroxylase in the liver and 25-hydroxyvitamin D -hydroxylase in the kidney. By binding to the vitamin D receptor (VDR), ercalcitriol activates VDR to interact with the retinoid X receptor (RXR), forming the VDR/RXR/cofactor complex, which regulates gene transcription. Because ercalcitriol circulates at picomolar concentrations and is highly lipophilic, it is difficult to quantify. |
| 500 µg | $62.00 |
| 1 mg | $118.00 |
| 5 mg | $496.00 |
|
60133-18-8 |
≥98%
|
 |
|
154.880952380952
|
ercalcitriol
|
1,25-Dihydroxyvitamin D2; Ro 17-6218
|
vitamins D receptors calcium calcitriol calcipotriol retinoid X metabolites liver kidneys VDR RXR genes transcription |
| 14 |
2012-02-20 |
11112 |
1-(4-Fluorobenzyl) piperazine (hydrochloride)
Potential drug of abuse
1-(4-Fluorobenzyl) piperazine is a substituted BZP with a potential for abuse. The physiological and toxicological properties of this compound have not been evaluated. This product is intended for forensic and research applications. 1-(4-Fluorobenzyl) piperazine is also used as a precursor in the synthesis of certain bioactive compounds. |
| 10 mg | $18.00 |
| 50 mg | $81.00 |
| 100 mg | $144.00 |
|
199672-06-5 |
≥98%
|
 |
|
137.111111111111
|
1-4-fluorobenzyl-piperazine-hydrochloride
|
|
70931-28-1 forensics piperazine phenylpiperazine designer drugs 5-HT serotonin BZP monoamine MDBP hydrochloride HCl |
| 15 |
2012-02-20 |
11204 |
1-(p-Fluorophenyl) piperazine (hydrochloride)
Potential drug of abuse
1-(p-Fluorophenyl) piperazine (hydrochloride) is a substituted phenylpiperazine with a potential for abuse. The physiological and toxicological properties of this compound have not been evaluated. This product is intended for forensic and research applications. |
| 10 mg | $18.00 |
| 50 mg | $81.00 |
| 100 mg | $144.00 |
|
64090-19-3 |
≥98%
|
 |
|
137.111111111111
|
1-p-fluorophenyl-piperazine-hydrochloride
|
pFPP; NSC 149515
|
NSC149515 NSC-149515 SBB003383 16141-90-5 forensics piperazine phenylpiperazine designer drugs 5-HT serotonin hydrochloride HCl |
| 16 |
2012-02-20 |
11128 |
3,4-Dimethoxymethamphetamine (hydrochloride)
An analog of MDMA
3,4-Dimethoxymethamphetamine (hydrochloride) (DMMA) is an analog of 3,4-methylenedioxymethamphetamine (MDMA), a psychoactive drug and research chemical of the phenethylamine and amphetamine chemical classes. DMMA appears to interfere with monoamine transport, inhibiting uptake of noradrenalin and serotonin transporters (Kis = 22.8 and 7.7 μM and IC50s = 253.4 and 108 μM, respectively). DMMA is significantly less potent than MDMA (Kis = 0.6 and 2.5 μM and IC50s = 6.6 and 34.8 μM for MDMA inhibition of noradrenalin and serotonin transporters, respectively). |
| 5 mg | $49.00 |
| 10 mg | $93.00 |
| 50 mg | $392.00 |
|
70932-18-2 |
≥97%
|
 |
|
156.064209407330
|
3-4-dimethoxymethamphetamine-hydrochloride
|
3,4-DMMA
|
33236-61-2 52370-71-5 HCl hydrochloride analogs forensics methamphetamines designer drugs amphetamines ecstasy MDMA phenethylamines serotonin norepinephrine dopamine 5-HT noradrenalin |
| 17 |
2012-02-20 |
11321 |
Cyclopamine
An inhibitor of hedgehog signaling
Cyclopamine is a natural steroidal alkaloid that inhibits signaling through the hedgehog pathway at the level of the pathway activator Smoothened. By altering gene expression in this signaling sequence, cyclopamine induces defects in morphogenesis, first observed in chicks and sheep as cyclopia. As a readout of action, cyclopamine inhibits hedgehog-dependent expression of Pax7 with an IC50 value of 24 nM. Although teratogenic during development, cyclopamine has potential applications in the treatment of cancer. |
| 1 mg | $14.00 |
| 5 mg | $56.00 |
| 10 mg | $84.00 |
|
4449-51-8 |
≥98%
|
 |
|
141.668551258441
|
cyclopamine
|
Jervine; 11-Deoxojervine
|
11051-96-0 26108-61-2 veratraman 11-deoxyjervine 11 deoxyjervine hedgehogs development teratogen cancers smoothened inhibitors cyclopia genes expressions signal transduction inhibits inhibition signaling steroids alkaloids pathways pax7 |
| 18 |
2012-02-20 |
11333 |
Diethylcathinone (hydrochloride)
A stimulant drug and appetite suppressant
Diethylcathinone is a stimulant drug of the phenethylamine, amphetamine, and cathinone chemical classes that is used as an appetite suppressant. It functions as an inactive prodrug that only becomes active when further metabolized to ethcathinone, a selective norepinephrine releasing agent. In the US, diethylcathinone is classified as a Schedule IV controlled substance, with low potential for abuse. |
| 5 mg | $35.00 |
| 10 mg | $67.00 |
| 50 mg | $280.00 |
|
134-80-5 |
≥98%
|
 |
|
163.394003967916
|
diethylcathinone-hydrochloride
|
Menutil; Moderatan; Tenuate
|
dospan tenuate-dospan amfepramone magrex retard lineal-rivo lineal rivo tepanil ten-tab Nu-dispoz regenon EINECS 205-156-5 CHEBI:643703 LS-125146 AC-16025 D03801 90-84-6 4830-79-9 parabolin phepranon prefamone modulor fepranon frekentine keramik keramin hydrochloride HCl forensics phenethylamines cathinones amphetamines designer drugs appetite suppressants prodrugs ethcathinone norepinephrine |
| 19 |
2012-02-17 |
9001190 |
4-Methyl-α-pyrrolidinobutiophenone (hydrochloride)
A designer drug
4-Methyl-α-pyrrolidinobutiophenone (MPBP) is a synthetic cathinone with psychoactive properties which has recently been identified in party pills and powders. The metabolism of MPBP has been characterized. The biological and toxicological properties of this compound are unknown. This product is intended for forensic and research applications. |
| 5 mg | $49.00 |
| 10 mg | $93.00 |
| 50 mg | $392.00 |
|
1214-15-9 |
≥98%
|
 |
|
234.779600470636
|
4-methyl-pyrrolidinobutiophenone-hydrochloride
|
4-MPBP; F 1938
|
732180-91-5 forensics phenethylamines amphetamines cathinones designer drugs 4-methyl-α-pyrrolidinobutyrophenone 4 MPBP 4MPBP synthetic party pills powders metabolism |
| 20 |
2012-02-17 |
10824 |
JWH 031
A synthetic cannabinoid
JWH 031 is a synthetic cannabinoid (CB) with a relatively low binding affinity for the central CB1 receptor (Ki = 399 nM). Despite its low affinity for CB1, this pyrrole-based cannabinoid is efficacious in reducing spontaneous activity and increasing antinociception in mice. This product is intended for forensic and research applications. |
| 5 mg | $30.00 |
| 10 mg | $57.00 |
| 25 mg | $135.00 |
|
162934-74-9 |
≥98%
|
 |
|
128.455464481906
|
jwh-031
|
|
JWH-031 JWH031 JWH31 JWH-31 JWH31 JWHs cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic central peripheral mice |
| 21 |
2012-02-16 |
10009875 |
16-phenoxy Prostaglandin F2α ethyl amide
A prodrug of a potent FP receptor agonist
Ethyl amides of PGs serve as prodrugs, as they are hydrolyzed in certain tissues to generate the bioactive free acid. |
| 1 mg | $74.00 |
| 5 mg | $312.00 |
| 10 mg | $546.00 |
|
951319-59-8 |
≥98%
|
 |
|
98.423889069439
|
16-phenoxy-prostaglandin-f2-ethyl-amide
|
16-phenoxy PGF2α ethyl amide; CAYMAX™ 517
|
PGF2α prostaglandins PGs analogs FP receptors agonists luteolytic activity prodrugs tissues free acids smooth muscles ovine luteal cells |
| 22 |
2012-02-16 |
11164 |
5-Azacytidine
A DNA methyltransferase inhibitor
5-Azacytidine, a chemical analogue of the DNA and RNA nucleoside cytidine, is an inhibitor of DNA methyltransferases, potentially serving to reverse epigenetic changes. It reduces hypermethylation associated with certain diseases, including myelodysplastic syndromes (IC50s = 2.4 and 2.6 μM for in vitro anti-myeloma activity) and cancer (IC50s ~ 0.4 μM for inhibiting proliferation of various cancer cell lines). 5-Azacytidine has a reported half-life of 17 hours and is considerably cytotoxic; it must be incorporated into DNA to covalently trap DNA methyltransferases. |
| 50 mg | $15.00 |
| 100 mg | $29.00 |
| 250 mg | $68.00 |
|
320-67-2 |
≥95%
|
 |
|
99.058782856185
|
5-azacytidine
|
Ladakamycin; 5-AzaC; NSC 103-627; U 18496; Vidaza; WR 183027; NSC 102816; Mylosar; Antibiotic U 18496
|
52934-49-3 292869-98-8 ledakamycin azacitidine 5-azacitidine 5 azacitidine 5 azacytidine 5-AZCR 5-AZC 5-AC methyltransferases histones cancers epigenetics cytidine inhibitors DNA RNA inhibits inhibition diseases cells |
| 23 |
2012-02-16 |
11214 |
NKH477 (hydrochloride)
Water-soluble analog of forskolin
NKH477 is a water-soluble analog of forskolin which has both inotropic and vasodilator effects when administered intravenously. Like forskolin, NKH477 activates adenylyl cyclases without altering the activity of phosphodiesterases or sodium/potassium ATPases. This compound stimulates cardiac (type V) adenylyl cyclase more potently than other isoforms. NKH477 relaxes guinea pig tracheal smooth muscle precontracted with histamine with an EC50 of 32.6 nM. |
| 1 mg | $19.00 |
| 5 mg | $76.00 |
| 10 mg | $114.00 |
|
138605-00-2 |
≥95%
|
 |
|
150.244444444444
|
nkh477-hydrochloride
|
Colforsin Dapropate (hydrochloride); Adehl
|
113462-26-3 adenylate cyclase adenylyl cAMP cyclic AMP vascular diseases cardiovascular cardiac hypotension hypertension analogs cardiac smooth muscles histamines |
| 24 |
2012-02-16 |
11450 |
PU-H71 (hydrate)
An HSP90 inhibitor with anti-cancer effects
PU-H71 (hydrate) is a purine scaffold HSP90 inhibitor that has potent in vitro anti-myeloma activity in both drug-sensitive (MM-1S, RPMI-8226/S, INA-6, NCI-H929, U266) and drug-resistant (MM-1R, RPMI-8226/Dox40, OMP-1) human myeloma cell lines (IC50s = 100-300 nM). It also demonstrates considerable efficacy inhibiting growth of triple-negative breast cancer tumor cell lines MDA-MB-468, MDA-MB-231, and HCC-1806 (IC50s = 65, 140, and 87 nM, respectively), diffuse large B-cell lymphomas (GI50 = 1.39 μM), and various hepatocellular carcinoma cell lines (GI50s < 3 μM). |
| 1 mg | $35.00 |
| 5 mg | $158.00 |
| 10 mg | $280.00 |
|
1202865-65-3 |
≥98%
|
 |
|
93.333333333333
|
pu-h71-hydrate
|
|
NSC750424 NSC-750424 NSC 750424 873436-91-0 heat shock proteins HSP90 anti-cancers inhibitors chaperones purine scaffold myeloma triple-negative breast diffuse large B-cells lymphomas hepatocellular carcinomas signal transduction cycles inhibits inhibition MM-1S RPMI-8226/S INA-6 NCI-H929 U266 MM-1R RPMI-8226/Dox40 OMP-1 humans melanoma tumors MDA-MB-468 MDA-MB-231 HCC-1806 |
| 25 |
2012-02-15 |
11219 |
DMABA-d10 NHS ester
An internal standard for the quantification of DMABA NHS ester
DMABA-d10 NHS ester is intended for use in combination with DMABA NHS ester (Item No. 11216) as a derivatizing reagent for PE lipids in order to facilitate MS characterization and to quantify relative changes in their abundance. |
| 1 mg | $87.00 |
| 5 mg | $392.00 |
| 10 mg | $696.00 |
|
1175002-05-7 |
9% deuterated forms (d1-d10)
|
 |
|
171.481481481481
|
dmaba-d10-nhs-ester
|
|
GC/MS deuterium deuterateds internal standards LC/MS GC-MS LC-MS mass spectrometry MS phosphatidylethanolamines FAAH fatty acids synthesis PUFA polyunsaturated fatty acyl phospholipids probes electorspray tandem PE lipids markers |